Breast Cancer 2026: Navigating the forks in the road

Breast Cancer 2026: Navigating the forks in the road

Author: Siobhan Davies, Research Consultant, Beyond Blue 2025 delivered a remarkable volume of breast cancer data, with striking results across multiple subtypes and treatment settings. As we move into 2026, these advances need to find their place, and physicians are...
Mind the (Trust) Gap

Mind the (Trust) Gap

Authors: Jenny Fletcher – Marketing Director, Mike Pepp – Senior Commercial Consultant, Sam Hope – CEO, Beyond Blue Over the holidays, an article caught our eye: Trust Gap: Why Patients Turn to TikTok Instead of Pharmaceutical Messaging by the Global...
The BTKi Rollercoaster in MS Continues to Surprise

The BTKi Rollercoaster in MS Continues to Surprise

Author: Nikita Shah, Beyond Neurology The rollercoaster in the MS fairground has taken another sharp turn. Tolebrutinib has missed its primary endpoint in the Phase 3 PERSEUS trial in PPMS, and the already delayed FDA decision for its nrSPMS indication now looks...